High-performance liquid chromatographic method for mycophenolic acid and its glucuronide in serum and urine

Journal of Clinical Pharmacy and Therapeutics

Volumn 28, Issue 1, 2003, Pages 17-22

  Teshima, Daisuke ^a   Otsubo, K ^a   Kitagawa, N ^a   Yoshimura, S ^b   Itoh, Y ^a   Oishi, R ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Shin Koga Hospital   (Japan)

Author keywords

Mycophenolic acid; Mycophenolic acid glucuronide; Serum; Solid phase extraction; Urine

Indexed keywords

ACETONITRILE; BENZOIC ACID; BUFFER; DRUG METABOLITE; GLUCURONIDE; METHANOL; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYCOPHENOLIC ACID GLUCORONIDE; NITROGEN; PHOSPHATE; UNCLASSIFIED DRUG;

ACCURACY; ANALYTICAL EQUIPMENT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG URINE LEVEL; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY TRANSPLANTATION; SOLID PHASE EXTRACTION; URINALYSIS;

ADMINISTRATION, ORAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; GLUCURONATES; GLUCURONIDES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; PRODRUGS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0037293162     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2003.00450.x     Document Type: Article

References (15)

1. Hale MD, Nicholls AJ, Bullingham RES et al. (1998) The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clinical Pharmacology and Therapeutics, 64, 672-683.
2. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. (1997) Mycophenolate mofetil in allograft recipients. Transplantation, 63, 39-47.
3. Ransom JT. (1995) Mechanism of action of mycophenolate mofetil. Therapeutic Drug Monitoring, 17, 681-684.
4. Mackenzie PI. (2000) Identification of uridine diphosphate glucuronosyltransferases involved in the metabolism and clearance of mycophenolic acid. Therapeutic Drug Monitoring, 22, 10-13.
5. Bullingham R, Monroe S, Nicholls A, Hale M. (1996) Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. Journal of Clinical Pharmacology, 36, 315-324.
6. Wollenberg K, Krumme B, Schollmeyer P, Kirste G. (1998) Pharmacokinetics of mycophenolic acid after renal transplantation. Transplantation Proceedings, 30, 2237-2239.
7. European Mycophenolate Mofetil Cooperative Study Group (1995) Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet, 345, 1321-1325.
8. Shaw LM, Mick R, Nowak I, Korecka M, Brayman KL. (1998) Pharmacokinetics of mycophenolic acid in renal transplantation patients with delayed graft function. Journal Of Clinical Pharmacology, 38, 268-275.
9. Weber LT, Lamersdorf T, Shipkova M et al. (1999) Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. Therapeutic Drug Monitoring, 21, 498-506.
10. Mourad M, Malaise J, Eddour DC et al. (2001) Correlation of mycophenolic acid pharmacokinetic parameters with aide effects in kidney transplantation patients treated with mycophenolate mofetil. Clinical Chemistry, 47, 88-94.
11. Jain A, Venkataramanan R, Hamad IS et al. (2001) Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplantation patients treated with tacrolimus. Journal of Clinical Pharmacology, 41, 268-276.
12. Huang JJZ, Kiang H, Tarnowski TL. (1997) Simultaneous determination of mycophenolic acid and its glucuronide conjugate in human plasma by single-run ion-pairing method. Journal of Chromatography B, 698, 293-300.
13. Jones CE, Taylor PJ, Johnson AG. (1998) High-performance liquid chromatography determination of mycophenolic acid and its glucuronide metabolite in human plasma. Journal of Chromatography B, 708, 229-234.
14. Hosotsubo H, Takahara S, Kokado Y et al. (2001) Rapid and simultaneous determination of mycophenolic acid and its glucuronide conjugate in human plasma by ion-pair reversed-phase high-performance liquid chromatography using isocratic elution. Journal of Chromatography B, 753, 315-320.
15. Wiwattanawongsa K, Heinzen EL, Kemp DC, Dupuis RE, Smith PC. (2001) Determination of mycophenolic acid and its phenol glucuronide metabolite in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography B, 763, 35-45.